A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery.
about
Amiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cellsMolecular mechanisms for enhanced DNA vaccine immunogenicity.Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo.Technologies for enhanced efficacy of DNA vaccines.Vaccine delivery using nanoparticles.Liposomal vaccine delivery systems.Novel antigen delivery technologies: a review.Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.Enhancing tumor specific immune responses by transcutaneous vaccination.Dendrosome-dendriplex inside liposomes: as a gene delivery system.A Respiratory Syncytial Virus vaccine based on the Small Hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults: a first-in-humans study.Engineering T7 bacteriophage as a potential DNA vaccine targeting delivery vector.
P2860
Q28481556-5049CFE1-892F-4912-BAF9-12B41A7102B2Q30366743-B34C1931-DFB8-4A14-A9E2-8EC62020880DQ33853324-C6A354EE-4128-4CCD-8E6F-8F87AFA75D6AQ35802958-45AC6638-42C9-41AD-A2D4-F5FA1D13F7F8Q36712817-D78BAAA9-7705-4959-ACD6-A7BD6AD64419Q37854063-25463DC0-EFB3-4FD9-BF11-880C2667F773Q38383368-DBB91726-B32D-48C9-AF1E-BCA8B8F58E6FQ38730774-57D3ECBD-C036-43A0-AEC6-37CA4878D704Q49932505-A3A3C03B-C258-44DC-951C-D57612C6703EQ50268214-44C36F3E-6BD5-47F8-B9BE-986EBE29F3F1Q52607180-487DE860-9E8C-4908-BCA0-432316B9BA77Q52646448-91C1F853-0F9C-4550-9869-C6C442587EDF
P2860
A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A liposome-based platform, Vac ...... in vivo nucleic acid delivery.
@en
A liposome-based platform, Vac ...... in vivo nucleic acid delivery.
@nl
type
label
A liposome-based platform, Vac ...... in vivo nucleic acid delivery.
@en
A liposome-based platform, Vac ...... in vivo nucleic acid delivery.
@nl
prefLabel
A liposome-based platform, Vac ...... in vivo nucleic acid delivery.
@en
A liposome-based platform, Vac ...... in vivo nucleic acid delivery.
@nl
P2093
P1433
P1476
A liposome-based platform, Vac ...... in vivo nucleic acid delivery
@en
P2093
Antar Fuentes-Ortega
Marc Mansour
Mohan Karkada
Tara Quinton
P304
P356
10.1016/J.VACCINE.2010.07.025
P407
P577
2010-07-23T00:00:00Z